Virpax to Initiate Investigational New Drug (IND) Enabling Studies for Epoladerm(TM)
BERWYN, PA / ACCESSWIRE / March 10, 2021 / Virpax® Pharmaceuticals Inc. ("Virpax" or the "Company") (NASDAQ:VRPX), today announced that...
BERWYN, PA / ACCESSWIRE / March 10, 2021 / Virpax® Pharmaceuticals Inc. ("Virpax" or the "Company") (NASDAQ:VRPX), today announced that...
Manufacturers in the pegfilgrastim biosimilar market are pushing for high-potential areas of HIV and cancer to provide affordable alternatives to...
Superior CBD at Affordable Prices LAS VEGAS, NV / ACCESSWIRE / March 10, 2021 / Megola, Inc. (OTC:MGON) (the "Company"),...
NEW YORK, NY / ACCESSWIRE / March 10, 2021 / The future is full of exciting new technologies. Some of...
- Oppenheimer 31st Annual Healthcare Conference - March 16th - 18th - Maxim Group 2021 Emerging Growth Virtual Conference -...
Reaxys and LexisNexis Intellectual Property teams join forces to advance strategic insights across IP, patent data and analytics for chemistry...
VANCOUVER, BC / ACCESSWIRE / March 10, 2021 / XPhyto Therapeutics Corp. (CSE:XPHY / OTCQB:XPHYF / FSE:4XT) ("XPhyto" or the...